Filing Details

Accession Number:
0000899243-19-014293
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-21 20:00:38
Reporting Period:
2019-05-18
Accepted Time:
2019-05-21 20:00:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1351288 Gw Pharmaceuticals Plc GWPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754154 M. Scott Giacobello Sovereign House, Vision Park, Histon
Cambridge X0 CB24 9BZ
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-05-18 8,136 $0.00 91,320 No 4 M Direct
Ordinary Shares Disposition 2019-05-20 4,224 $14.52 87,096 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Restricted Stock Units Disposition 2019-05-18 8,136 $0.00 8,136 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-05-18 2019-05-18 No 4 M Direct
Footnotes
  1. Vesting of restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018. These ordinary shares are subsequently converted into American Depositary Shares ("ADS") of the Issuer.
  2. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.27 U.S. Dollars as of May 17, 2019.
  3. Includes 47,496 and 25,152 ordinary shares underlying restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018 and Form 4 filed on March 5, 2019, respectively.
  4. Represented by ADSs.
  5. The price reported in Column 4 is price per ordinary share converted from price per ADS.
  6. The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 8,136 ordinary shares vesting on May 18, 2019 and expiring on March 15, 2020. These securities are restricted stock units with a nominal exercise price and vest automatically upon vesting date.